Business Context and Reporting Period
The source filing identifies the registrant as Ambac Financial Group, Inc., not Octave Specialty Group Inc. This unaudited Form 10-Q covers the three and nine months ended September 30, 2016, with comparative periods ended September 30, 2015. Ambac operates through Financial Guarantee and Financial Services segments and is primarily managing an active runoff of its insured portfolio and related financial-services contracts.
Ambac Assurance Corporation’s ability to write new business has been impaired since 2007, and dividend payments to the parent are highly unlikely for the foreseeable future. Management states that substantial doubt exists regarding Ambac’s ability to continue as a going concern, although the financial statements were prepared on a going-concern basis.
Key Financial Metrics
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Net premiums earned | $53.2 million, versus $71.5 million | $147.4 million, versus $198.1 million |
| Net investment income | $90.9 million, versus $64.2 million | $222.5 million, versus $201.9 million |
| Total revenues | $145.0 million, versus $87.7 million | $268.7 million, versus $473.9 million |
| Pre-tax income | $116.7 million, versus a $388.2 million loss | $191.1 million, versus $114.5 million |
| Net income attributable to common stockholders | $101.5 million, versus a $391.0 million loss | $169.5 million, versus $106.4 million |
| Diluted earnings per share | $2.22, versus $(8.66) | $3.74, versus $2.30 |
| Operating cash flow | Not separately presented | $825.5 million, versus $82.0 million |
Reported net income margins were approximately 70% for the quarter and 63% for the nine months, but these ratios were materially affected by fair-value movements, recoveries, reserve changes and other nonrecurring or non-operating items.
- Loss and loss expense benefit was $69.2 million in the quarter and $227.0 million for the nine months, compared with benefits of $133.2 million and $431.6 million, respectively, in the prior-year periods.
- Derivative product losses were $14.5 million in the quarter and $134.3 million for the nine months, compared with losses of $65.1 million and $51.9 million.
- Insurance intangible amortization was $44.6 million in the quarter and $134.5 million for the nine months.
- No goodwill impairment was recorded in 2016; the prior-year periods included a $514.5 million non-cash goodwill impairment charge.
Balance Sheet, Debt and Liquidity
| Balance Sheet Item | September 30, 2016 | December 31, 2015 |
|---|---|---|
| Total assets | $24.016 billion | $23.728 billion |
| Total liabilities | $21.839 billion | $21.770 billion |
| Total stockholders’ equity | $2.176 billion | $1.958 billion |
| Cash and cash equivalents | $21.2 million | $35.7 million |
| Total investments | $6.606 billion | $5.645 billion |
| Long-term debt, excluding VIE debt | $1.110 billion | $1.125 billion |
| VIE long-term debt at fair value | $11.930 billion | $12.328 billion |
| Loss and loss expense reserves | $4.208 billion | $4.088 billion |
Parent-company liquidity consisted primarily of approximately $213.1 million of cash and liquid investments, plus $97.9 million of less-liquid Ambac Assurance-insured securities and surplus notes. Ambac’s cash balance declined during the nine months because investing and financing outflows exceeded operating cash generation.
Operating cash flow of $825.5 million was driven substantially by recoveries, including a $992.8 million net representation-and-warranty settlement with JPMorgan and $99.1 million of net recoveries related to the Countrywide investor settlement. These cash flows may not recur at comparable levels.
Ambac posted approximately $88.9 million of collateral for investment agreements and approximately $282.0 million of collateral and margin for financial-services derivatives. All reported collateral and margin obligations were being met at September 30, 2016.
Material Changes Versus the Prior Comparable Period
- Quarterly net income improved substantially because the 2015 quarter included the $514.5 million goodwill impairment, while 2016 benefited from higher investment income, lower derivative losses and positive VIE income.
- Nine-month net income increased to $169.5 million from $106.4 million, despite lower premiums, lower realized investment gains, greater derivative losses and losses from consolidated VIEs.
- Net premiums earned declined 25.6% for the quarter and 25.6% for the nine months, reflecting continued portfolio runoff and lower accelerated premiums.
- Total guaranteed net par outstanding declined to $86.4 billion from $108.3 billion at year-end 2015. Below-investment-grade net par declined to $17.3 billion from $19.8 billion, but increased as a percentage of the remaining portfolio.
- Ambac executed commutations and cancellations reducing gross par by approximately $898.0 million, including $431.0 million of student-loan exposure and $467.0 million related to securities issued by a consolidated VIE.
- Shareholders’ equity increased by approximately $218 million, primarily from net income and other comprehensive income, including unrealized investment gains, partly offset by foreign-currency translation losses.
- Adjusted book value increased to $1.449 billion, or $32.12 per share, from $1.116 billion, or $24.78 per share, at December 31, 2015. This is a non-GAAP measure.
Outlook, Risks, Contingencies and Unusual Items
- Going concern: Management disclosed substantial doubt about continuing as a going concern, principally because of regulatory oversight, rehabilitation proceedings and uncertainty over Ambac Assurance’s ability to deliver value or dividends to the parent.
- Segregated Account: Ambac Assurance is evaluating transactions that could monetize assets or restructure debt and insurance obligations, but no agreement had been reached. Any transaction would require approvals from the relevant boards, OCI and the Rehabilitation Court.
- Regulatory capital: Ambac Assurance statutory policyholder surplus was $921.9 million and exceeded the $100 million minimum surplus amount. However, Ambac UK reported a Solvency II capital deficit of £139.0 million as of June 30, 2016, compared with a £379.0 million regulatory capital requirement.
- Puerto Rico: Ambac had approximately $2.1 billion of Puerto Rico net par exposure. Defaults, payment moratoria, PROMESA-related restructuring and litigation stays could materially increase claims, losses and liquidity needs.
- Reserve sensitivity: Management estimated reasonably possible additional losses of approximately $2.010 billion for RMBS, $157 million for student loans, $1.154 billion for public finance and $418 million for other credits including Ambac UK under specified stress scenarios. These are not forecasts.
- Recovery uncertainty: Recorded representation-and-warranty subrogation recoveries were approximately $1.923 billion. Actual recoveries depend on litigation, counterparty collectability, timing and regulatory intervention.
- Brexit and foreign exchange: Management estimated an approximately $46 million adverse economic impact from currency movements since March 31, 2016 on certain foreign investments, premium receivables and reserves. Future currency movements could materially affect earnings and equity.
- Internal controls: Disclosure controls were deemed ineffective because of a previously identified material weakness involving modeling of residential mortgage-backed collateral losses. Management expected remediation by December 31, 2016.
- Litigation: A new putative securities class action alleged inadequate disclosures concerning risk management, controls and Puerto Rico exposure. Management considered the claims without merit but could not predict the outcome.
- No formal earnings guidance: The filing does not provide numerical earnings or revenue guidance. Management’s stated strategy is continued runoff, asset and liability management, loss recovery, cost efficiency and possible strategic transactions.
Important Facts for Investors to Verify
- Confirm that the filing belongs to Ambac Financial Group, Inc. and reconcile the mismatch with the requested company name.
- Assess the sustainability of the $825.5 million nine-month operating cash flow, particularly the contribution from large litigation and settlement recoveries.
- Review the going-concern disclosure, dividend restrictions and the ability of Ambac Assurance and Ambac UK to meet regulatory and policyholder obligations.
- Evaluate reserve adequacy against Puerto Rico, RMBS, public-finance and student-loan stress sensitivities.
- Verify the collectability and timing of the $1.923 billion of recorded representation-and-warranty recoveries.
- Review the material weakness in RMBS loss modeling and confirm whether remediation was completed and controls became effective.
- Distinguish GAAP results from non-GAAP Operating Earnings and Adjusted Book Value, which depend on management-selected adjustments.
- Monitor collateral calls, derivative termination rights, surplus-note payments, rehabilitation proceedings and any restructuring proposals.